TSX:CRDL

Cardiol Therapeutics Inc. Class A Stock Predictions

Toronto Stock Exchange > Healthcare > Drug Manufacturers—Specialty & Generic

Open Broker Account

$2.74

-0.1000 (-3.52%)

At Close: May 02, 2024

Currently predicting for Mon, 6 May 2024

Trading levels for CRDL.TO

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	2.98	8.76 %
		R2	2.90	5.69 %
		R1	2.84	3.80 %
Current price:			2.74
	Support	S1	2.68	-2.34 %
		S2	2.62	-4.23 %
		S3	2.54	-7.30 %

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	2.84	3.65 %
		R2	2.83	3.28 %
		R1	2.78	1.46 %
Current price			2.74
	Support	S1	2.50	-8.76%
		S2	2.47	-9.85%
		S3	2.34	-14.78%

CRDL.TO Predictions History

2 years ago
JS predicted that CRDL.TO for 2022-04-25 is going $2.08 (-2.80%)

2 years ago
mikhailkutsar00.313461 predicted that CRDL.TO for 2022-04-25 is going $1.62 (-22.86%)

Rank:

2 years ago
JS predicted that CRDL.TO for 2022-04-04 is going $1.76 (-7.37%)

About Cardiol Therapeutics Inc. Class A

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx as a cardioprotective therapy to reduce cardiovascular and respirat... CRDL.TO Profile

Golden Star

Ticker	Date	Change	Price
BSCQ	Apr 30	0.393%	$19.09
EQC	Apr 30	1.76%	$18.72
HRB	Apr 30	1.69%	$47.23
REG	Apr 30	1.35%	$59.22
INGR	Apr 30	0.576%	$114.59
BSJP	Apr 29	0.175%	$22.91
LYG	Apr 29	0.781%	$2.56
ORA	Apr 29	3.46%	$64.48
DHT	Apr 24	4.34%	$11.28
LPLA	Apr 19	2.62%	$262.59

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In